Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
430 participants
OBSERVATIONAL
2004-05-31
2006-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Resynchronization Therapy Device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is willing to sign Permission for Access to and Use of Health Information form
* Patient is willing and able to comply with follow-up visits through six months
Exclusion Criteria
* Patient is participating in any concurrent study that could confound the results for either study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Thompson, MD
Role: PRINCIPAL_INVESTIGATOR
Tennessee Cardiovascular Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Newport Beach, California, United States
Trumbull, Connecticut, United States
Daytona Beach, Florida, United States
Augusta, Georgia, United States
Kankakee, Illinois, United States
Indianapolis, Indiana, United States
Des Moines, Iowa, United States
Owensboro, Kentucky, United States
New Orleans, Louisiana, United States
Salisbury, Maryland, United States
Burlington, Massachusetts, United States
Detroit, Michigan, United States
Traverse City, Michigan, United States
Minneapolis, Minnesota, United States
Mexico, Missouri, United States
Omaha, Nebraska, United States
Bridgewater, New Jersey, United States
Englewood, New Jersey, United States
Charlotte, North Carolina, United States
Dayton, Ohio, United States
Lyndhurst, Ohio, United States
Oklahoma City, Oklahoma, United States
Portland, Oregon, United States
Abington, Pennsylvania, United States
Doylestown, Pennsylvania, United States
Columbia, South Carolina, United States
Nashville, Tennessee, United States
Houston, Texas, United States
Fairfax, Virginia, United States
Richmond, Virginia, United States
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
239
Identifier Type: -
Identifier Source: org_study_id